Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RD

Robert D. Dillard — 24 Patents

Eli Lilly: 24 patents #92 of 2,858Top 4%
SCShionogi & Co.: 2 patents #396 of 1,054Top 40%
Zionsville, IN: #43 of 470 inventorsTop 10%
Indiana: #1,160 of 33,936 inventorsTop 4%
Overall (All Time): #168,038 of 4,157,543Top 5%
24 Patents All Time
Robert D. Dillard has been granted 24 US patents while listed as an inventor at Eli Lilly. The first was granted in 1989 and the most recent in March 2004. Robert D. Dillard ranks #168,038 of 4,157,543 US inventors in our database (top 4.0%). Patent records list Robert D. Dillard in Zionsville, IN, US.

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
6713645 Substituted tricyclics Nicholas J. Bach, Susan E. Draheim, Edward David Mihelich, Jason Scott Sawyer, Douglas Wade Beight +17 more 2004-03-30 $108,187,000
6645976 Indolizine SPLA2inhibitors Sanji Hagishita, Mitsuaki Ohtani 2003-11-11 $237,756,000
6451839 Indole sPLA2 inhibitors Nicholas J. Bach, Susan E. Draheim, Edward David Mihelich, Tulio Suarez 2002-09-17 $209,972,000
6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors Nicholas J. Bach, Susan E. Draheim 2002-08-13 $98,121,000
6252084 1H-indole-3-acetamide sPLA2 inhibitors Nicholas J. Bach, Susan E. Draheim, Robert Hermann, Richard W. Schevitz 2001-06-26 $203,013,000
6214876 Indene-1-acetamide sPLA2 inhibitors Sanji Hagishita, Mitsuaki Ohtani 2001-04-10 $548,518,000
6177440 Substituted tricyclics Nicholas J. Bach, Susan E. Draheim, Edward David Mihelich, Jason Scott Sawyer, Douglas Wade Beight +17 more 2001-01-23 $624,202,000
6175021 1H-indole-3-glyoxylamide sPLA2 inhibitors Nicholas J. Bach, Susan E. Draheim 2001-01-16 $243,198,000
5919774 Pyrroles as sPLA.sub.2 inhibitors Nicholas J. Bach, Susan E. Draheim 1999-07-06 $61,549,000
5919810 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors Nicholas J. Bach, Susan E. Draheim 1999-07-06 $61,549,000
5919943 Process for preparing 1H-indole-3-glyoxylamides Nicholas J. Bach, Susan E. Draheim 1999-07-06 $61,549,000
5733923 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors Nicholas J. Bach, Susan E. Draheim 1998-03-31 $86,352,000
5684034 1H-indole-3-acetamide sPLA.sub.2 inhibitors Nicholas J. Bach, Susan E. Draheim, Robert Hermann, Richard W. Schevitz 1997-11-04 $237,638,000
5654326 1H-indole-3-glyoxylamide SPLA.sub.2 inhibitors Nicholas J. Bach, Susan E. Draheim 1997-08-05 $93,697,000
5641800 1H-indole-1-functional sPLA.sub.2 inhibitors Nicholas J. Bach, Susan E. Draheim 1997-06-24 $61,514,000
5578634 1H-indole-3-acetic acid hydrazide sPLA.sub.2 inhibitors Nicholas J. Bach, Susan E. Draheim, Robert Hermann, Richard W. Schevitz 1996-11-26 $31,094,000
5552441 Leukotriene B4 antagonists J. Scott Sawyer, Michael Joseph Sofia 1996-09-03 $12,735,000
5462954 Substituted phenyl phenol leukotriene antagonists S. Richard Baker, Paul E. Floreancig, J. Scott Sawyer, Michael Joseph Sofia 1995-10-31 $19,796,000
5393768 Leukotriene antagonists 1995-02-28 $24,532,000
5324743 Leukotriene B.sub.4 antagonists J. Scott Sawyer, Michael Joseph Sofia 1994-06-28 $99,937,000
5105017 Leukotriene antagonist intermediates 1992-04-14 $78,152,000
4874777 Leukotriene antagonists F. Patrick Carr, Doris E. McCullough 1989-10-17 $14,287,000
4853398 Leukotriene antagonists and use thereas F. Patrick Carr, Doris E. McCullough 1989-08-01 $61,933,000
4820722 Disubstituted tetrazoles and their use as leukotriene antagonists F. Patrick Carr, Winston S. Marshall, Doris E. McCullough 1989-04-11 $6,684,000